Embudo, Rubelyn .
HRN: 21-29-31 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2022
AMPICILLIN 1GM (VIAL)
05/03/2022
05/09/2022
IV
2g
Q6
PROM Thinly MSAF
Waiting Final Action